Skip to main content
Top

07-03-2018 | Inflammation | Article

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease

Journal: Advances in Therapy

Authors: Fernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, Fabio Ayala, Vincenzo Bettoli, Luca Bianchi, Luca Cimino, Antonio Costanzo, Antonio Cristaudo, Salvatore D’Angelo, Marco Daperno, Anna Chiara Fostini, Mauro Galeazzi, Michele Gilio, Paolo Gionchetti, Paolo Gisondi, Ennio Lubrano, Antonio Marchesoni, Annamaria Offidani, Ambrogio Orlando, Daniela Pugliese, Carlo Salvarani, Raffaele Scarpa, Maurizio Vecchi, Giampiero Girolomoni

Publisher: Springer Healthcare

Abstract

Introduction

Immune-mediated inflammatory diseases (IMIDs) are chronic autoimmune conditions that share common pathophysiologic mechanisms. The optimal management of patients with IMIDs remains challenging because the coexistence of different conditions requires the intervention of several specialists. The aim of this study was to develop a series of statements defining overarching principles that guide the implementation of a multidisciplinary approach for the management of spondyloarthritis (SpA)-related IMIDs including SpA, psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis and uveitis.

Methods

A Delphi consensus-based approach was used to identify a core set of statements. The process included development of initial questions by a steering committee, an exhaustive search of the literature using complementary approaches to identify potential statements and two Delphi voting rounds for finalization of the statements.

Results

Consensus was achieved on the related nature of IMIDs, the existence of a high prevalence of multiple IMIDs in a single patient and the fact that a multidisciplinary approach can result in a more extensive evaluation and comprehensive approach to treatment. The goals of a multidisciplinary team should be to increase diagnosis of concomitant IMIDs, improve the decision-making process, and increase patient satisfaction and adherence. Early referral and diagnosis, early recognition of concomitant IMIDs and optimizing treatment to improve patient quality of life are some of the advantages of using multidisciplinary teams. To be effective, a multidisciplinary team should be equipped with the appropriate tools for diagnosis and follow-up, and at a minimum the multidisciplinary team should include a dermatologist, gastroenterologist and rheumatologist; providing psychologic support via a psychologist and involving an ophthalmologist, general practitioners and nurses in multidisciplinary care is also important.

Conclusion

The present Delphi consensus identified a set of overarching principles that may be useful for implementation of a multidisciplinary approach for the management of SpA-related IMIDs.

Funding

Aristea and Hippocrates.
Literature
1.
Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345(5):340–50.CrossRefPubMed
2.
Kuek A, Hazleman BL, Ostor AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007;83(978):251–60.CrossRefPubMedPubMedCentral
3.
Brophy S, Pavy S, Lewis P, et al. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol. 2001;28(12):2667–73.PubMed
4.
Blandizzi C, Gionchetti P, Armuzzi A, et al. The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases. Int J Immunopathol Pharmacol. 2014;27(1 Suppl):1–10.CrossRefPubMed
5.
Canete JD, Dauden E, Queiro R, et al. Recommendations for the coordinated management of psoriatic arthritis by rheumatologists and dermatologists: a Delphi study. Actas Dermosifiliogr. 2014;105(3):216–32.CrossRefPubMed
6.
Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510.CrossRefPubMed
7.
Olivieri I, Cantini F, Castiglione F, et al. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev. 2014;13(8):822–30.CrossRefPubMed
8.
van Erp SJ, Brakenhoff LK, van Gaalen FA, et al. Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow-up study. J Crohn’s Colitis. 2016;10(2):166–75.CrossRef
9.
National Institute for Health and Care Excellence. Rheumatoid arthritis in adults: management. 2009. http://​www.​nice.​org.​uk/​guidance/​cg79/​resources/​rheumatoid-arthritis-in-adults-management-pdf-975636823525. Accessed 29 Jun 2017.
10.
Coates LC, Kavanaugh A, Mease PJ, et al. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68(5):1060–71.PubMed
11.
van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978–91.CrossRefPubMed
12.
Bearne LM, Byrne AM, Segrave H, White CM. Multidisciplinary team care for people with rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Int. 2016;36(3):311–24.CrossRefPubMed
13.
Crossland V, Field R, Ainsworth P, Edwards CJ, Cherry L. Is there evidence to support multidisciplinary healthcare working in rheumatology? A systematic review of the literature. Musculoskeletal Care. 2015;13(1):51–66.CrossRefPubMed
14.
Louis E, Dotan I, Ghosh S, Mlynarsky L, Reenaers C, Schreiber S. Optimising the inflammatory bowel disease unit to improve quality of care: expert recommendations. J Crohn’s Colitis. 2015;9(8):685–91.CrossRef
15.
Migliore A, Cusano F, Bianchi G, Malara G, Epis O, De Pita O. Management of psoriatic arthritis: should the interaction between dermatologists and rheumatologists in clinical practice be intensified? J Biol Regul Homeost Agents. 2015;29(3):547–61.PubMed
16.
Vliet Vlieland TP, Li LC, MacKay C, Badley EM. Does everybody need a team? J Rheumatol. 2006;33(9):1897–9.PubMed
17.
Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008–15.PubMed
18.
Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376–80.CrossRefPubMedPubMedCentral
19.
Powell C. The Delphi technique: myths and realities. J Adv Nurs. 2003;41(4):376–82.CrossRefPubMed
20.
Henes JC, Ziupa E, Eisfelder M, et al. High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study. Rheumatol Int. 2014;34(2):227–34.CrossRefPubMed
21.
Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–35.CrossRefPubMed
22.
Villani AP, Rouzaud M, Sevrain M, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242–8.CrossRefPubMed
23.
Edson-Heredia E, Zhu B, Lefevre C, et al. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol. 2015;29(5):955–63.CrossRefPubMed
24.
Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(1):65–73.CrossRefPubMed
25.
Isene R, Bernklev T, Hoie O, et al. Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015;50(3):300–5.CrossRefPubMed
26.
Zippi M, Corrado C, Pica R, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20(46):17463–7.CrossRefPubMedPubMedCentral
27.
Karreman MC, Luime JJ, Hazes JMW, Weel A. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohn’s Colitis. 2017;11(5):631–42.
28.
Lapadula G, Marchesoni A, Armuzzi A, et al. Adalimumab in the treatment of immune-mediated diseases. Int J Immunopathol Pharmacol. 2014;27(1 Suppl):33–48.CrossRefPubMed
29.
D’Ambrosio EM, La Cava M, Tortorella P, Gharbiya M, Campanella M, Iannetti L. Clinical features and complications of the HLA-B27-associated acute anterior uveitis: a metanalysis. Semin Ophthalmol. 2017;32(6):689–701.CrossRefPubMed
30.
Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009;15(20):2449–55.CrossRefPubMedPubMedCentral
31.
Calvet X, Panes J, Alfaro N, et al. Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units. J Crohn’s Colitis. 2014;8(3):240–51.CrossRef
32.
Cobo-Ibanez T, Villaverde V, Seoane-Mato D, et al. Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review. Rheumatol Int. 2016;36(2):221–9.CrossRefPubMed
33.
Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res. 2012;304(1):7–13.CrossRefPubMed
34.
Luelmo J, Gratacos J, Moreno Martinez-Losa M, et al. A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis. Reumatol Clin. 2014;10(3):141–6.CrossRefPubMed
35.
Capeci W, Luchetti MM, Campanati A, et al. The multidisciplinary approach is the best option to achieve the improvement of disease activity and quality of life in patients affected by psoriatic arthritis: preliminary results of a monocentric study [Abstract THU0454]. Ann Rheum Dis. 2016;75(Suppl 2):356.CrossRef
36.
Esselens G, Westhovens R, Verschueren P. Effectiveness of an integrated outpatient care programme compared with present-day standard care in early rheumatoid arthritis. Musculoskeletal care. 2009;7(1):1–16.CrossRefPubMed
37.
Maravic M, Bozonnat MC, Sevezan A, et al. Preliminary evaluation of medical outcomes (including quality of life) and costs in incident RA cases receiving hospital-based multidisciplinary management. Jt Bone Spine. 2000;67(5):425–33.
38.
Vliet Vlieland TP. Multidisciplinary team care and outcomes in rheumatoid arthritis. Curr Opin Rheumatol. 2004;16(2):153–6.CrossRefPubMed
39.
Uutela T, Hannonen P, Kautiainen H, Hakala M, Hakkinen A. Sustained improvement of health-related quality of life in patients with early rheumatoid arthritis: a ten-year follow-up study. Clin Exp Rheumatol. 2011;29(1):65–71.PubMed
40.
Kjeken I, Bo I, Ronningen A, et al. A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J Rehabil Med. 2013;45(3):260–7.CrossRefPubMed
41.
Garg A, Gladman D. Recognizing psoriatic arthritis in the dermatology clinic. J Am Acad Dermatol. 2010;63(5):733–48.CrossRefPubMed
42.
Weger W. An update on the diagnosis and management of psoriatic arthritis. G Ital Dermatol Venereol. 2011;146(1):1–8.PubMed
43.
Radtke MA, Mrowietz U, Feuerhahn J, et al. Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis. Journal der Deutschen Dermatologischen Gesellschaft J Ger Soc Dermatol JDDG. 2015;13(7):674–90.
44.
Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol. 2009;23(6):683–91.CrossRefPubMed
45.
Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045–50.CrossRefPubMed
46.
Olivieri I, D’Angelo S, Palazzi C, Padula A. Advances in the management of psoriatic arthritis. Nat Rev Rheumatol. 2014;10(9):531–42.CrossRefPubMed
47.
Richard MA, Barnetche T, Rouzaud M, et al. Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol. 2014;28(Suppl 5):3–12.CrossRefPubMed
48.
Mitchell R, Kremer A, Westwood N, Younge L, Ghosh S. Talking about life and IBD: a paradigm for improving patient-physician communication. J Crohn’s Colitis. 2009;3(1):1–3.CrossRef
49.
Kane SV, Brixner D, Rubin DT, Sewitch MJ. The challenge of compliance and persistence: focus on ulcerative colitis. J Manag Care Pharm. 2008;14(1):s2–12 (quiz s13-5).PubMed
50.
Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol. 2009;15(34):4234–9.CrossRefPubMedPubMedCentral
51.
Mishra S, Kancharla H, Dogra S, Sharma A. Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study). Br J Dermatol. 2017;176(3):765–70.CrossRefPubMed
52.
Ganatra B, Manoharan D, Akhras V. Use of a validated screening tool for psoriatic arthritis in dermatology clinics. BMJ Qual Improv Rep. 2015;4(1):u203335.w2644. https://​doi.​org/​10.​1136/​bmjquality.​u203335.​w2644
53.
National Institute for Health and Care Excellence. Psoriasis: assessment and management. 2012. http://​www.​nice.​org.​uk/​guidance/​cg153/​resources/​psoriasis-assessment-and-management-35109629621701. Accessed 29 Jun 2017.
54.
D’Angelo S, Palazzi C, Gilio M, Leccese P, Padula A, Olivieri I. Improvements in diagnostic tools for early detection of psoriatic arthritis. Expert Rev Clin Immunol. 2016;12(11):1209–15.CrossRefPubMed
55.
Danese S, Fiorino G, Mary JY, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative. J Crohn’s Colitis. 2015;9(8):601–6.CrossRef
56.
Fiorino G, Danese S. Diagnostic delay in Crohn’s disease: time for red flags. Dig Dis Sci. 2016;61(11):3097–8.CrossRefPubMed
57.
Revenas A, Opava CH, Ahlen H, Brusewitz M, Pettersson S, Asenlof P. Mobile internet service for self-management of physical activity in people with rheumatoid arthritis: evaluation of a test version. RMD Open. 2016;2(1):e000214.CrossRefPubMedPubMedCentral
58.
Hendrikx J, Fransen J, van Riel PL. Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare. RMD open. 2015;1(1):e000114.CrossRefPubMedPubMedCentral
59.
Kojima M, Kojima T, Suzuki S, et al. Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20(9):1193–200.CrossRefPubMed
60.
Jevtic V, Lingg G. Differential diagnosis of rheumatoid and psoriatic arthritis at an early stage in the small hand and foot joints using magnetic resonance imaging. Handchir Mikrochir Plast Chir. 2012;44(3):163–70.CrossRefPubMed
61.
Gutierrez M, Filippucci E, Salaffi F, Di Geso L, Grassi W. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis. 2011;70(6):1111–4.CrossRefPubMed
62.
Mandl P, Navarro-Compan V, Terslev L, et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015;74(7):1327–39.CrossRefPubMed
63.
Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohn’s Colitis. 2013;7(12):982–1018.CrossRef
64.
Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohn’s Colitis. 2013;7(7):556–85.CrossRef
65.
Abbouda A, Abicca I, Fabiani C, et al. Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations and ocular inflammation features. Semin Ophthalmol. 2017;32(6):715–20.CrossRefPubMed
66.
Generali E, Cantarini L, Selmi C. Ocular involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol. 2015;49(3):263–70.CrossRefPubMed
67.
Garcia-Vicuna R, Zarco P, Gonzalez CM, Vanaclocha F, Marin-Jimenez I, Cea-Calvo L. Two-year incidence of psoriasis, uveitis and inflammatory bowel disease in patients with spondyloarthritis: a study in the AQUILES cohort. Reumatol Clin. 2016;12(1):22–6.CrossRefPubMed
68.
Haroon M, O’Rourke M, Ramasamy P, Murphy CC, FitzGerald O. A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis. 2015;74(11):1990–5.CrossRefPubMed
69.
Bacconnier L, Rincheval N, Flipo RM, et al. Psychological distress over time in early rheumatoid arthritis: results from a longitudinal study in an early arthritis cohort. Rheumatology (Oxford). 2015;54(3):520–7.CrossRef
70.
Offidani E, Del Basso D, Prignago F, Tomba E. Discriminating the presence of psychological distress in patients suffering from psoriasis: an application of the clinimetric approach in dermatology. Acta Derm Venereol. 2016;96(217):69–73.PubMed
71.
Ryan S, McGuire B. Psychological predictors of pain severity, pain interference, depression, and anxiety in rheumatoid arthritis patients with chronic pain. Br J Health Psychol. 2016;21(2):336–50.CrossRefPubMed
72.
Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol. 2016;12(9):532–42.CrossRefPubMedPubMedCentral
73.
Knowles SR, Wilson JL, Connell WR, Kamm MA. Preliminary examination of the relations between disease activity, illness perceptions, coping strategies, and psychological morbidity in Crohn’s disease guided by the common sense model of illness. Inflamm Bowel Dis. 2011;17(12):2551–7.CrossRefPubMed
74.
Morgan C, McBeth J, Cordingley L, et al. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era. Rheumatology (Oxford). 2015;54(10):1780–91.CrossRef
75.
Tabibian A, Tabibian JH, Beckman LJ, Raffals LL, Papadakis KA, Kane SV. Predictors of health-related quality of life and adherence in Crohn’s disease and ulcerative colitis: implications for clinical management. Dig Dis Sci. 2015;60(5):1366–74.CrossRefPubMed
76.
Vangeli E, Bakhshi S, Baker A, et al. A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Adv Ther. 2015;32(11):983–1028.CrossRefPubMedPubMedCentral
77.
Chen Y, Xin T, Cheng AS. Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: a narrative review. J Dermatol. 2014;41(9):775–8.CrossRefPubMed
78.
Dissanayake RK, Bertouch JV. Psychosocial interventions as adjunct therapy for patients with rheumatoid arthritis: a systematic review. Int J Rheum Dis. 2010;13(4):324–34.CrossRefPubMed
79.
Meyfroidt S, Stevens J, De Lepeleire J, et al. A general practice perspective on early rheumatoid arthritis management: a qualitative study from Flanders. Eur J Gen pract. 2015;21(4):231–7.CrossRefPubMed
80.
Puchner R, Edlinger M, Mur E, et al. Interface management between general practitioners and rheumatologists-results of a survey defining a concept for future joint recommendations. PLoS One. 2016;11(1):e0146149.CrossRefPubMedPubMedCentral
81.
van Onna M, Gorter S, Maiburg B, Waagenaar G, van Tubergen A. Education improves referral of patients suspected of having spondyloarthritis by general practitioners: a study with unannounced standardised patients in daily practice. RMD open. 2015;1(1):e000152.CrossRefPubMedPubMedCentral
82.
van Onna M, Gorter S, van Meerendonk A, van Tubergen A. General practitioners’ perceptions of their ability to identify and refer patients with suspected axial spondyloarthritis: a qualitative study. J Rheumatol. 2014;41(5):897–901.CrossRefPubMed
83.
Amity CL, Schlenk EA, Gold KN, et al. Agreement of physicians and nurses performing tender and swollen joint counts in rheumatoid arthritis. J Clin Rheumatol. 2016;22(1):30–4.CrossRefPubMed
84.
Bala SV, Samuelson K, Hagell P, Svensson B, Fridlund B, Hesselgard K. The experience of care at nurse-led rheumatology clinics. Musculoskeletal Care. 2012;10(4):202–11.CrossRefPubMed
85.
Candelas G, Villaverde V, Garcia S, Guerra M, Leon MJ, Canete JD. Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: a systematic literature review. Rheumatol Int. 2016;36(11):1493–506.CrossRefPubMed
86.
Fall E, Chakroun N, Dalle N, Izaute M. Is patient education helpful in providing care for patients with rheumatoid arthritis? A qualitative study involving French nurses. Nurs Health Sci. 2013;15(3):346–52.CrossRefPubMed
87.
Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R, Moum B. Is patient reported outcome (PRO) affected by different follow-up regimens in inflammatory bowel disease (IBD)? A one year prospective, longitudinal comparison of nurse-led versus conventional follow-up. J Crohn’s Colitis. 2012;6(9):887–94.CrossRef
88.
Munoz-Fernandez S, Aguilar MD, Rodriguez A, et al. Evaluation of the impact of nursing clinics in the rheumatology services. Rheumatol Int. 2016;36(9):1309–17.CrossRefPubMed
89.
O’Connor M, Gaarenstroom J, Kemp K, Bager P, van der Woude CJ. N-ECCO survey results of nursing practice in caring for patients with Crohn’s disease or ulcerative colitis in Europe. J Crohn’s colitis. 2014;8(10):1300–7.CrossRef
90.
Primdahl J, Sorensen J, Horn HC, Petersen R, Horslev-Petersen K. Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity–patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis. 2014;73(2):357–64.CrossRefPubMed
91.
Solomon DH, Fraenkel L, Lu B, et al. Comparison of care provided in practices with nurse practitioners and physician assistants versus subspecialist physicians only: a cohort study of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2015;67(12):1664–70.CrossRefPubMedPubMedCentral
92.
Vinall-Collier K, Madill A, Firth J. A multi-centre study of interactional style in nurse specialist- and physician-led rheumatology clinics in the UK. Int J Nurs Stud. 2016;59:41–50.CrossRefPubMed
93.
Larsson I, Fridlund B, Arvidsson B, Teleman A, Svedberg P, Bergman S. A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial. BMC Musculoskelet Disord. 2015;16:354.CrossRefPubMedPubMedCentral
94.
Cottrell JE, Jonas M, Bergsten U, et al. The nurse’s role in addressing unmet treatment and management needs of patients with rheumatoid arthritis: Delphi-based recommendations. Int J Nurs Knowl. 2013;24(2):66–76.CrossRefPubMed
95.
Aldridge A. The role of the community nurse in psoriatic comorbidities interventions. Br J Community Nurs. 2014;19(1):38–42.CrossRefPubMed
96.
Queiro R, Coto P, Rodriguez J, et al. Multidisciplinary care models for patients with psoriatic arthritis. Reumatol Clin. 2017;13(2):85–90.CrossRefPubMed